Logo image of ECOR

ELECTROCORE INC (ECOR) Stock Fundamental Analysis

USA - NASDAQ:ECOR - US28531P2020 - Common Stock

5.03 USD
+0.12 (+2.44%)
Last: 10/20/2025, 8:00:01 PM
Fundamental Rating

3

Overall ECOR gets a fundamental rating of 3 out of 10. We evaluated ECOR against 190 industry peers in the Health Care Equipment & Supplies industry. ECOR scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ECOR is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ECOR had negative earnings in the past year.
ECOR had a negative operating cash flow in the past year.
ECOR had negative earnings in each of the past 5 years.
ECOR had a negative operating cash flow in each of the past 5 years.
ECOR Yearly Net Income VS EBIT VS OCF VS FCFECOR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M -50M

1.2 Ratios

With a Return On Assets value of -91.02%, ECOR is not doing good in the industry: 77.37% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -1190.57%, ECOR is doing worse than 87.89% of the companies in the same industry.
Industry RankSector Rank
ROA -91.02%
ROE -1190.57%
ROIC N/A
ROA(3y)-88.18%
ROA(5y)-75.86%
ROE(3y)-180.1%
ROE(5y)-137.89%
ROIC(3y)N/A
ROIC(5y)N/A
ECOR Yearly ROA, ROE, ROICECOR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K -2.5K

1.3 Margins

ECOR has a Gross Margin of 85.52%. This is amongst the best in the industry. ECOR outperforms 95.79% of its industry peers.
ECOR's Gross Margin has improved in the last couple of years.
ECOR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 85.52%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.4%
GM growth 5Y10.55%
ECOR Yearly Profit, Operating, Gross MarginsECOR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K

More info and screens

4

2. Health

2.1 Basic Checks

ECOR does not have a ROIC to compare to the WACC, probably because it is not profitable.
ECOR has more shares outstanding than it did 1 year ago.
The number of shares outstanding for ECOR has been increased compared to 5 years ago.
There is no outstanding debt for ECOR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ECOR Yearly Shares OutstandingECOR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
ECOR Yearly Total Debt VS Total AssetsECOR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

ECOR has an Altman-Z score of -16.99. This is a bad value and indicates that ECOR is not financially healthy and even has some risk of bankruptcy.
ECOR's Altman-Z score of -16.99 is on the low side compared to the rest of the industry. ECOR is outperformed by 88.42% of its industry peers.
There is no outstanding debt for ECOR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -16.99
ROIC/WACCN/A
WACC8.66%
ECOR Yearly LT Debt VS Equity VS FCFECOR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M

2.3 Liquidity

ECOR has a Current Ratio of 1.10. This is a normal value and indicates that ECOR is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of ECOR (1.10) is worse than 86.84% of its industry peers.
A Quick Ratio of 0.95 indicates that ECOR may have some problems paying its short term obligations.
With a Quick ratio value of 0.95, ECOR is not doing good in the industry: 78.95% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.1
Quick Ratio 0.95
ECOR Yearly Current Assets VS Current LiabilitesECOR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 26.03% over the past year.
The Revenue has grown by 30.15% in the past year. This is a very strong growth!
ECOR shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 60.15% yearly.
EPS 1Y (TTM)26.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-15.79%
Revenue 1Y (TTM)30.15%
Revenue growth 3Y66.56%
Revenue growth 5Y60.15%
Sales Q2Q%20.23%

3.2 Future

ECOR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 28.31% yearly.
ECOR is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 27.40% yearly.
EPS Next Y-4.2%
EPS Next 2Y24.51%
EPS Next 3Y28.31%
EPS Next 5YN/A
Revenue Next Year22.37%
Revenue Next 2Y32.91%
Revenue Next 3Y32.39%
Revenue Next 5Y27.4%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ECOR Yearly Revenue VS EstimatesECOR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 20M 40M 60M 80M
ECOR Yearly EPS VS EstimatesECOR Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -5 -10 -15 -20 -25

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ECOR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ECOR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ECOR Price Earnings VS Forward Price EarningsECOR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ECOR Per share dataECOR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3

4.3 Compensation for Growth

A more expensive valuation may be justified as ECOR's earnings are expected to grow with 28.31% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.51%
EPS Next 3Y28.31%

More info and screens

0

5. Dividend

5.1 Amount

ECOR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ELECTROCORE INC

NASDAQ:ECOR (10/20/2025, 8:00:01 PM)

5.03

+0.12 (+2.44%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-11 2025-11-11/amc
Inst Owners15.51%
Inst Owner Change0%
Ins Owners28.29%
Ins Owner Change2.02%
Market Cap39.94M
Analysts84
Price Target21.5 (327.44%)
Short Float %9.19%
Short Ratio5.44
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-19.74%
Min EPS beat(2)-40.66%
Max EPS beat(2)1.19%
EPS beat(4)2
Avg EPS beat(4)-14.48%
Min EPS beat(4)-40.66%
Max EPS beat(4)9.28%
EPS beat(8)6
Avg EPS beat(8)-2.43%
EPS beat(12)6
Avg EPS beat(12)-5.19%
EPS beat(16)7
Avg EPS beat(16)-4%
Revenue beat(2)1
Avg Revenue beat(2)-1.44%
Min Revenue beat(2)-3.11%
Max Revenue beat(2)0.24%
Revenue beat(4)1
Avg Revenue beat(4)-1.48%
Min Revenue beat(4)-3.11%
Max Revenue beat(4)0.24%
Revenue beat(8)5
Avg Revenue beat(8)4.24%
Revenue beat(12)6
Avg Revenue beat(12)1.36%
Revenue beat(16)8
Avg Revenue beat(16)1.08%
PT rev (1m)0%
PT rev (3m)0.96%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-56.58%
EPS NY rev (1m)0%
EPS NY rev (3m)-33.35%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.3%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.03%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.44
P/FCF N/A
P/OCF N/A
P/B 35.88
P/tB 35.88
EV/EBITDA N/A
EPS(TTM)-1.62
EYN/A
EPS(NY)-0.72
Fwd EYN/A
FCF(TTM)-0.96
FCFYN/A
OCF(TTM)-0.96
OCFYN/A
SpS3.49
BVpS0.14
TBVpS0.14
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -91.02%
ROE -1190.57%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 85.52%
FCFM N/A
ROA(3y)-88.18%
ROA(5y)-75.86%
ROE(3y)-180.1%
ROE(5y)-137.89%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.4%
GM growth 5Y10.55%
F-Score4
Asset Turnover1.9
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.1
Quick Ratio 0.95
Altman-Z -16.99
F-Score4
WACC8.66%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)26.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-15.79%
EPS Next Y-4.2%
EPS Next 2Y24.51%
EPS Next 3Y28.31%
EPS Next 5YN/A
Revenue 1Y (TTM)30.15%
Revenue growth 3Y66.56%
Revenue growth 5Y60.15%
Sales Q2Q%20.23%
Revenue Next Year22.37%
Revenue Next 2Y32.91%
Revenue Next 3Y32.39%
Revenue Next 5Y27.4%
EBIT growth 1Y10.17%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year83.42%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y57.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y57.33%
OCF growth 3YN/A
OCF growth 5YN/A